Perceptive Advisors LLC, 10% Owner at Acrivon Therapeutics, Inc. (ACRV), sold 2,789,904 shares at $1.95 ($5.1M) on 2025-04-25, disclosed to the SEC on 2025-04-29.
Open-market sale of $5.1M ACRV by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.95 | 1,054,669 | $2.1M | 40.0% |
| 2 | $1.95 | 1,054,669 | $2.1M | 40.0% |
| 3 | $1.56 | 215,283 | $336K | 6.5% |
| 4 | $1.56 | 215,283 | $336K | 6.5% |
| 5 | $1.41 | 250,000 | $353K | 6.9% |
| Total | $1.84 avg | 2,789,904 |
| $5.1M |
| 100% |
| Filing → |
| ACRV | SELL | 2025-05-01 | $2.0M | — | Filing → |
| VRCA | BUY | 2023-12-26 | $3.6M | — | Filing → |
| ATXS | BUY | 2023-12-22 | $4.6M | — | Filing → |